Getinge AB (publ) (STO:GETI.B)
Sweden · Delayed Price · Currency is SEK 205.80
-2.20 (-1.06%)
Jul 6, 2026, 4:26 PM CET
Getinge AB Market Cap
Getinge AB has a market cap or net worth of 56.65 billion as of July 6, 2026. Its market cap has increased by 12.98% in one year.
Market Cap
56.65B
Enterprise Value
63.69B
Revenue
34.09B
Ranking
n/a
PE Ratio
24.02
Stock Price
205.80
Market Cap Chart
Since March 15, 1996, Getinge AB's market cap has increased from 15.22B to 56.65B, an increase of 272.32%. That is a compound annual growth rate of 4.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 56.65B | -4.94% |
| Dec 30, 2025 | 59.59B | 20.52% |
| Dec 30, 2024 | 49.45B | -19.06% |
| Dec 29, 2023 | 61.09B | 3.70% |
| Dec 30, 2022 | 58.91B | -45.25% |
| Dec 30, 2021 | 107.61B | 105.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sectra AB | 56.99B |
| Elekta AB | 19.98B |
| Nolato AB | 13.79B |
| Vitrolife AB | 12.34B |
| Xvivo Perfusion AB | 8.82B |
| MedCap AB | 8.19B |
| CellaVision AB | 3.49B |
| C-Rad AB | 1.23B |